$AMRX
Amneal Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations
AMRX chart
What traders are saying about $AMRX
Latest postsAmneal Pharmaceuticals, Inc. news
- Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers
Yahoo Finance ·
- UBS Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $28
Moomoo ·
- TGTX Q3 Earnings & Revenues Beat Estimates, 2026 View Raised, Stock Up
Yahoo Finance ·
- IBRX Q3 Earnings Miss, Anktiva Sales Decline Q/Q, Stock Down 18%
Yahoo Finance ·
- CRMD to Acquire HRTX Assets for $223M Upfront to Expand Portfolio
Yahoo Finance ·
- Q3 revenue rises to $863M, but Amneal (AMRX) swings from profit to loss.
Stock Titan ·
- Top 3 Insider Owned Growth Stocks To Watch In November 2026
Yahoo Finance ·
- Amneal Pharmaceuticals (AMRX) Lifts 2026 Guidance, Is The 12% Undervalued View Enough?
Simply Wall St ·
- Amneal Pharmaceuticals (AMRX) Lifts 2026 Guidance, Is The Upside Already Priced In?
Yahoo Finance ·
- Amneal Pharmaceuticals (AMRX) Institutional Ownership 2026
MarketBeat ·
- Intellia's Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus
Yahoo Finance ·
- Agenus' Q3 Earnings Match Estimates, Revenues Miss Mark, Stock Down
Yahoo Finance ·
Amneal Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.02B | $2.79B | $2.39B | $2.21B |
| Net income | $72.1M | -$116.9M | -$84.0M | -$270.6M |
| Diluted EPS | $0.22 | $-0.38 | $-0.48 | $-0.86 |
| Total assets (year end) | $3.68B | $3.50B | $3.47B | $3.80B |
| Cash and equivalents (year end) | $282.0M | $110.6M | $91.5M | $26.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amneal Pharmaceuticals, Inc.
- Ticker
- AMRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Fiscal year end
- December 31
- SEC CIK
- 1723128
- Former names
- Atlas Holdings, Inc.
Frequently asked questions
What exchange is Amneal Pharmaceuticals, Inc. listed on?
Amneal Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AMRX.
What industry is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
When does Amneal Pharmaceuticals, Inc.'s fiscal year end?
Amneal Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Amneal Pharmaceuticals, Inc. report?
Amneal Pharmaceuticals, Inc. reported $3.02B in revenue for calendar year 2025, according to its SEC filings.